Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate and Cytisinicline Development Update

Go back to Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate and Cytisinicline Development Update

Achieve Life Sciences (ACHV) Tops Q3 EPS by 17c

November 12, 2020 4:20 PM EST

Achieve Life Sciences (NASDAQ: ACHV) reported Q3 EPS of ($1.14), $0.17 better than the analyst estimate of ($1.31). Revenue for the quarter came in at $0 , versus $0 reported last year.

As of September 30, 2020, the company\'s cash, cash equivalents, and restricted cash was $22.4 million. Total... More